Jean Yves Mary

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Thierry Façon, Jean Yves Mary, Cyrille Hulin et al. · The Lancet · 2007 · 870 citations

Hematological Malignancy, Cell Therapy, Transplantation +14

Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand

Marc Lallemant, Gonzague Jourdain, Sophie Le Cœur et al. · New England Journal of Medicine · 2004 · 459 citations

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Régis Peffault de Latour, Jean Yves Mary, Célia Salanoubat et al. · Blood · 2008 · 370 citations

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 234 citations · Full text

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Thierry Façon, Meletios Α. Dimopoulos, Nathalie Meuleman et al. · Leukemia · 2019 · 214 citations · Full text

Simplified Frailty Scale, Prognosis, Transplantation Medicine +17